Determination of the anticoagulant effects of new oral anticoagulants: an unmet need
Thromboembolic diseases require anticoagulation for their prevention and treatment. New oral anticoagulants, specifically direct factor Xa and thrombin inhibitors, were developed to overcome the limitations of conventional anticoagulants. Their benefit has been demonstrated using fixed doses without...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
10 Jan 2014
|
| In: |
Expert review of hematology
Year: 2012, Volume: 5, Issue: 1, Pages: 107-113 |
| ISSN: | 1747-4094 |
| DOI: | 10.1586/ehm.11.79 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1586/ehm.11.79 Verlag, Volltext: https://doi.org/10.1586/ehm.11.79 
|
| Author Notes: | Job Harenberg, Svetlana Marx, Sandra Erdle & Roland Krämer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1578427541 | ||
| 003 | DE-627 | ||
| 005 | 20230427065631.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180809r20142012xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1586/ehm.11.79 |2 doi | |
| 035 | |a (DE-627)1578427541 | ||
| 035 | |a (DE-576)508427541 | ||
| 035 | |a (DE-599)BSZ508427541 | ||
| 035 | |a (OCoLC)1341016577 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Harenberg, Job |d 1950- |e VerfasserIn |0 (DE-588)108825507 |0 (DE-627)655891498 |0 (DE-576)339563745 |4 aut | |
| 245 | 1 | 0 | |a Determination of the anticoagulant effects of new oral anticoagulants |b an unmet need |c Job Harenberg, Svetlana Marx, Sandra Erdle & Roland Krämer |
| 264 | 1 | |c 10 Jan 2014 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.08.2018 | ||
| 520 | |a Thromboembolic diseases require anticoagulation for their prevention and treatment. New oral anticoagulants, specifically direct factor Xa and thrombin inhibitors, were developed to overcome the limitations of conventional anticoagulants. Their benefit has been demonstrated using fixed doses without laboratory-guided dose adjustment for patients following elective knee and hip replacement, treatment of venous thromboembolism and prevention of embolic events in atrial fibrillation. These anticoagulants are excreted by glomerular filtration at a rate of between 25 and 80%. Thus, lower doses are required for patients with impaired renal function. Therefore, determination of the anticoagulant effects may be needed in other specific patient populations. Prothrombin time, activated partial thromboplastin time, prothrombin-induced clotting time, ecarin clotting time, hemoclot assay, other specific coagulation assays and chromogenic substrate are available to determine the effect of the anticoagulants. Standardization of methods, development of point-of-care tests and identification of patient groups is ongoing. | ||
| 534 | |c 2012 | ||
| 650 | 4 | |a activated partial thromboplastin time | |
| 650 | 4 | |a apixaban | |
| 650 | 4 | |a atrial fibrillation | |
| 650 | 4 | |a chromogenic substrate assays | |
| 650 | 4 | |a dabigatran | |
| 650 | 4 | |a oral anticoagulants | |
| 650 | 4 | |a prothrombin time | |
| 650 | 4 | |a prothrombinase-induced clotting time | |
| 650 | 4 | |a rivaroxaban | |
| 650 | 4 | |a venous thromboembolism | |
| 700 | 1 | |a Hetjens, Svetlana |d 1983- |e VerfasserIn |0 (DE-588)1031801979 |0 (DE-627)737600284 |0 (DE-576)379534223 |4 aut | |
| 700 | 1 | |a Erdle, Sandra |d 1989- |e VerfasserIn |0 (DE-588)1048606996 |0 (DE-627)780716493 |0 (DE-576)402454499 |4 aut | |
| 700 | 1 | |a Krämer, Roland |e VerfasserIn |0 (DE-588)1020469730 |0 (DE-627)691227861 |0 (DE-576)360500331 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert review of hematology |d Abingdon, Oxon : Taylor & Francis, 2008 |g 5(2012), 1, Seite 107-113 |h Online-Ressource |w (DE-627)600594971 |w (DE-600)2496298-3 |w (DE-576)398101124 |x 1747-4094 |7 nnas |a Determination of the anticoagulant effects of new oral anticoagulants an unmet need |
| 773 | 1 | 8 | |g volume:5 |g year:2012 |g number:1 |g pages:107-113 |g extent:7 |a Determination of the anticoagulant effects of new oral anticoagulants an unmet need |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1586/ehm.11.79 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1586/ehm.11.79 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180809 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 1020469730 |a Krämer, Roland |m 1020469730:Krämer, Roland |d 120000 |d 120200 |e 120000PK1020469730 |e 120200PK1020469730 |k 0/120000/ |k 1/120000/120200/ |p 4 |y j | ||
| 998 | |g 1048606996 |a Erdle, Sandra |m 1048606996:Erdle, Sandra |d 60000 |d 65400 |e 60000PE1048606996 |e 65400PE1048606996 |k 0/60000/ |k 1/60000/65400/ |p 3 | ||
| 998 | |g 1031801979 |a Hetjens, Svetlana |m 1031801979:Hetjens, Svetlana |d 60000 |d 60200 |d 60250 |e 60000PH1031801979 |e 60200PH1031801979 |e 60250PH1031801979 |k 0/60000/ |k 1/60000/60200/ |k 2/60000/60200/60250/ |p 2 | ||
| 998 | |g 108825507 |a Harenberg, Job |m 108825507:Harenberg, Job |d 60000 |d 65400 |e 60000PH108825507 |e 65400PH108825507 |k 0/60000/ |k 1/60000/65400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1578427541 |e 3020510511 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 09.08.2018"],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.2008 -"],"recId":"600594971","disp":"Determination of the anticoagulant effects of new oral anticoagulants an unmet needExpert review of hematology","language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"7","issue":"1","text":"5(2012), 1, Seite 107-113","volume":"5","year":"2012","pages":"107-113"},"id":{"eki":["600594971"],"issn":["1747-4094"],"zdb":["2496298-3"]},"note":["Gesehen am 01.09.15"],"origin":[{"dateIssuedDisp":"2008-","publisher":"Taylor & Francis ; Informa Healthcare","publisherPlace":"Abingdon, Oxon ; London","dateIssuedKey":"2008"}],"title":[{"title_sort":"Expert review of hematology","title":"Expert review of hematology"}]}],"id":{"doi":["10.1586/ehm.11.79"],"eki":["1578427541"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"7 S."}],"title":[{"title":"Determination of the anticoagulant effects of new oral anticoagulants","subtitle":"an unmet need","title_sort":"Determination of the anticoagulant effects of new oral anticoagulants"}],"language":["eng"],"name":{"displayForm":["Job Harenberg, Svetlana Marx, Sandra Erdle & Roland Krämer"]},"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"10 Jan 2014"}],"recId":"1578427541","person":[{"family":"Harenberg","given":"Job","display":"Harenberg, Job","role":"aut"},{"family":"Hetjens","display":"Hetjens, Svetlana","given":"Svetlana","role":"aut"},{"family":"Erdle","display":"Erdle, Sandra","given":"Sandra","role":"aut"},{"role":"aut","family":"Krämer","given":"Roland","display":"Krämer, Roland"}]} | ||
| SRT | |a HARENBERGJDETERMINAT1020 | ||